Avid Bioservices (CDMO) Competitors $12.36 0.00 (0.00%) (As of 12/17/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends CDMO vs. XENE, FOLD, MRUS, ACAD, MOR, ZLAB, GMTX, VERA, BHC, and ARWRShould you be buying Avid Bioservices stock or one of its competitors? The main competitors of Avid Bioservices include Xenon Pharmaceuticals (XENE), Amicus Therapeutics (FOLD), Merus (MRUS), ACADIA Pharmaceuticals (ACAD), MorphoSys (MOR), Zai Lab (ZLAB), Gemini Therapeutics (GMTX), Vera Therapeutics (VERA), Bausch Health Companies (BHC), and Arrowhead Pharmaceuticals (ARWR). These companies are all part of the "pharmaceutical preparations" industry. Avid Bioservices vs. Xenon Pharmaceuticals Amicus Therapeutics Merus ACADIA Pharmaceuticals MorphoSys Zai Lab Gemini Therapeutics Vera Therapeutics Bausch Health Companies Arrowhead Pharmaceuticals Avid Bioservices (NASDAQ:CDMO) and Xenon Pharmaceuticals (NASDAQ:XENE) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their community ranking, earnings, analyst recommendations, institutional ownership, profitability, valuation, media sentiment, dividends and risk. Which has better valuation & earnings, CDMO or XENE? Avid Bioservices has higher revenue and earnings than Xenon Pharmaceuticals. Xenon Pharmaceuticals is trading at a lower price-to-earnings ratio than Avid Bioservices, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAvid Bioservices$150.45M5.25-$140.75M-$2.39-5.17Xenon Pharmaceuticals$9.43M333.74-$182.39M-$2.82-14.64 Do analysts rate CDMO or XENE? Avid Bioservices currently has a consensus target price of $12.25, suggesting a potential downside of 0.89%. Xenon Pharmaceuticals has a consensus target price of $56.33, suggesting a potential upside of 36.47%. Given Xenon Pharmaceuticals' stronger consensus rating and higher probable upside, analysts clearly believe Xenon Pharmaceuticals is more favorable than Avid Bioservices.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avid Bioservices 0 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Xenon Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 3.10 Does the MarketBeat Community believe in CDMO or XENE? Xenon Pharmaceuticals received 49 more outperform votes than Avid Bioservices when rated by MarketBeat users. Likewise, 69.95% of users gave Xenon Pharmaceuticals an outperform vote while only 65.95% of users gave Avid Bioservices an outperform vote. CompanyUnderperformOutperformAvid BioservicesOutperform Votes37065.95% Underperform Votes19134.05% Xenon PharmaceuticalsOutperform Votes41969.95% Underperform Votes18030.05% Which has more volatility and risk, CDMO or XENE? Avid Bioservices has a beta of 1.44, suggesting that its share price is 44% more volatile than the S&P 500. Comparatively, Xenon Pharmaceuticals has a beta of 1.19, suggesting that its share price is 19% more volatile than the S&P 500. Does the media favor CDMO or XENE? In the previous week, Xenon Pharmaceuticals had 2 more articles in the media than Avid Bioservices. MarketBeat recorded 6 mentions for Xenon Pharmaceuticals and 4 mentions for Avid Bioservices. Xenon Pharmaceuticals' average media sentiment score of 0.96 beat Avid Bioservices' score of 0.15 indicating that Xenon Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avid Bioservices 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Xenon Pharmaceuticals 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is CDMO or XENE more profitable? Xenon Pharmaceuticals has a net margin of 0.00% compared to Avid Bioservices' net margin of -101.07%. Xenon Pharmaceuticals' return on equity of -24.69% beat Avid Bioservices' return on equity.Company Net Margins Return on Equity Return on Assets Avid Bioservices-101.07% -33.18% -8.45% Xenon Pharmaceuticals N/A -24.69%-23.68% Do insiders and institutionals have more ownership in CDMO or XENE? 97.2% of Avid Bioservices shares are owned by institutional investors. Comparatively, 95.4% of Xenon Pharmaceuticals shares are owned by institutional investors. 3.1% of Avid Bioservices shares are owned by insiders. Comparatively, 5.5% of Xenon Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. SummaryXenon Pharmaceuticals beats Avid Bioservices on 12 of the 19 factors compared between the two stocks. Ad Porter & CompanyHow to piss off your liberal friends… and profit from itElon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies.To get the full details on the fake “energy crisis” of America, watch this now Get Avid Bioservices News Delivered to You Automatically Sign up to receive the latest news and ratings for CDMO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CDMO vs. The Competition Export to ExcelMetricAvid BioservicesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$790.58M$6.86B$5.18B$9.31BDividend YieldN/A3.06%4.78%4.06%P/E Ratio-5.1710.75130.2217.53Price / Sales5.25287.791,246.14139.51Price / Cash80.0156.6541.2337.95Price / Book17.665.394.884.92Net Income-$140.75M$152.04M$119.65M$225.78M7 Day Performance1.06%-4.32%16.62%-1.56%1 Month Performance1.64%2.80%16.34%6.68%1 Year Performance102.29%17.30%35.38%22.48% Avid Bioservices Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CDMOAvid Bioservices2.5177 of 5 stars$12.36flat$12.25-0.9%+102.0%$790.58M$150.45M-5.17371XENEXenon Pharmaceuticals2.7658 of 5 stars$41.20+2.9%$56.90+38.1%-0.3%$3.14B$9.43M-14.20251FOLDAmicus Therapeutics4.3924 of 5 stars$9.84+5.1%$16.88+71.5%-22.2%$2.94B$493.67M-28.71480Analyst DowngradeMRUSMerus2.9299 of 5 stars$42.89+0.1%$85.64+99.7%+77.9%$2.94B$35.93M-10.8437ACADACADIA Pharmaceuticals3.9301 of 5 stars$17.28+0.1%$25.60+48.1%-39.1%$2.88B$726.44M22.13510MORMorphoSys0.0818 of 5 stars$18.96+2.4%$14.33-24.4%N/A$2.86B$238.28M-5.45730ZLABZai Lab2.5215 of 5 stars$26.07-1.0%$55.00+111.0%-10.1%$2.83B$355.75M-9.512,175GMTXGemini TherapeuticsN/A$64.89+1.0%N/A+12.7%$2.81BN/A-64.8930VERAVera Therapeutics3.6914 of 5 stars$44.030.0%$59.22+34.5%+174.4%$2.79BN/A-16.8840BHCBausch Health Companies2.7451 of 5 stars$7.66-1.9%$7.75+1.2%+5.5%$2.77B$8.76B-15.9620,270Short Interest ↑ARWRArrowhead Pharmaceuticals4.2965 of 5 stars$22.17+1.5%$42.70+92.6%-22.0%$2.76B$3.55M-4.35400Short Interest ↑Analyst Revision Related Companies and Tools Related Companies XENE Alternatives FOLD Alternatives MRUS Alternatives ACAD Alternatives MOR Alternatives ZLAB Alternatives GMTX Alternatives VERA Alternatives BHC Alternatives ARWR Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CDMO) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avid Bioservices, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avid Bioservices With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CDMO Stock Alerts